These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 15900997

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF), and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)].
    Katori H, Tsukuda M, Ishitoya J, Mikami Y, Matsuda H, Tanigaki Y, Horiuchi C, Ikeda Y, Kimura M, Taguchi T, Hirose S, Yoshida T, Takahashi M, Sakuma Y, Yamamoto K, Sato N.
    Nihon Jibiinkoka Gakkai Kaiho; 2005 Feb; 108(2):157-63. PubMed ID: 15765729
    [Abstract] [Full Text] [Related]

  • 3. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
    Prestwich RJ, Öksüz DÇ, Dyker K, Coyle C, Şen M.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e237-43. PubMed ID: 21620580
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Tsukuda M, Ishitoya J, Matsuda H, Horiuchi C, Taguchi T, Takahashi M, Nishimura G, Kawakami M, Watanabe M, Niho T, Kawano T, Ikeda Y, Sakuma Y, Shiono O, Komatsu M.
    Cancer Chemother Pharmacol; 2010 Sep 15; 66(4):729-36. PubMed ID: 20033810
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
    Teo M, Karakaya E, Young CA, Dyker KE, Coyle C, Sen M, Prestwich RJ.
    Clin Oncol (R Coll Radiol); 2013 Nov 15; 25(11):647-53. PubMed ID: 23948462
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck.
    Komatsu M, Shiono O, Taguchi T, Sakuma Y, Nishimura G, Sano D, Sakuma N, Yabuki K, Arai Y, Takahashi M, Isitoya J, Oridate N.
    Jpn J Clin Oncol; 2014 May 15; 44(5):416-21. PubMed ID: 24688084
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck.
    Strojan P, Grašič Kuhar C, Žumer B, Kadivec M, Karner K, Fajdiga I, Jančar B, Gale N, Poljak M, Kocjan BJ, Zakotnik B.
    Head Neck; 2014 Nov 15; 36(11):1555-61. PubMed ID: 24123552
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.
    Okano S, Enokida T, Onoe T, Ota Y, Motegi A, Zenda S, Akimoto T, Tahara M.
    Int J Clin Oncol; 2019 Jul 15; 24(7):789-797. PubMed ID: 30796560
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Schultz JD, Bran G, Anders C, Sadick H, Faber A, Hörmann K, Sauter A.
    Oncol Rep; 2010 Nov 15; 24(5):1213-6. PubMed ID: 20878112
    [Abstract] [Full Text] [Related]

  • 20. A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.
    Zhang M, Chen Y, Wu W, Jin F, Li Y, Long J, Luo X, Gong X, Chen X, Liu L, Tang H, Wang Z.
    J Cancer Res Clin Oncol; 2023 Dec 15; 149(20):18081-18091. PubMed ID: 37985501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.